NVO logo

Novo Nordisk A/S (NVO) Net income

annual net income:

$14.65B+$2.50B(+20.60%)
December 31, 2024

Summary

  • As of today (April 12, 2025), NVO annual net profit is $14.65 billion, with the most recent change of +$2.50 billion (+20.60%) on December 31, 2024.
  • During the last 3 years, NVO annual net income has risen by +$7.05 billion (+92.81%).
  • NVO annual net income is now at all-time high.

Performance

NVO Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

quarterly net income:

$4.03B+$10.31M(+0.26%)
December 31, 2024

Summary

  • As of today (April 12, 2025), NVO quarterly net profit is $4.03 billion, with the most recent change of +$10.31 million (+0.26%) on December 31, 2024.
  • Over the past year, NVO quarterly net income has stayed the same.
  • NVO quarterly net income is now at all-time high.

Performance

NVO quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

TTM net income:

$14.65B+$863.97M(+6.27%)
December 31, 2024

Summary

  • As of today (April 12, 2025), NVO TTM net profit is $14.65 billion, with the most recent change of +$863.97 million (+6.27%) on December 31, 2024.
  • Over the past year, NVO TTM net income has stayed the same.
  • NVO TTM net income is now at all-time high.

Performance

NVO TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

NVO Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.6%0.0%0.0%
3 y3 years+92.8%+140.8%+92.6%
5 y5 years+150.9%+212.2%+143.8%

NVO Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+92.8%at high+115.9%at high+91.6%
5 y5-yearat high+150.9%at high+170.2%at high+143.8%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

Novo Nordisk A/S Net income History

DateAnnualQuarterlyTTM
Dec 2024
$14.65B(+20.6%)
$4.03B(+0.3%)
$14.65B(+6.3%)
Sep 2024
-
$4.02B(+39.0%)
$13.79B(+5.7%)
Jun 2024
-
$2.89B(-21.8%)
$13.05B(+0.4%)
Mar 2024
-
$3.70B(+16.8%)
$12.99B(+6.9%)
Dec 2023
$12.15B(+54.4%)
$3.17B(-3.4%)
$12.15B(+12.0%)
Sep 2023
-
$3.28B(+15.6%)
$10.85B(+14.0%)
Jun 2023
-
$2.84B(-0.6%)
$9.52B(+10.9%)
Mar 2023
-
$2.86B(+52.9%)
$8.58B(+9.1%)
Dec 2022
$7.87B(+3.6%)
$1.87B(-4.2%)
$7.87B(+2.5%)
Sep 2022
-
$1.95B(+2.3%)
$7.68B(+0.4%)
Jun 2022
-
$1.91B(-11.1%)
$7.65B(-0.8%)
Mar 2022
-
$2.14B(+28.0%)
$7.70B(+1.3%)
Dec 2021
$7.60B(+17.7%)
$1.68B(-12.8%)
$7.61B(+2.5%)
Sep 2021
-
$1.92B(-2.2%)
$7.42B(+4.3%)
Jun 2021
-
$1.96B(-4.0%)
$7.12B(+5.9%)
Mar 2021
-
$2.05B(+37.1%)
$6.73B(+4.5%)
Dec 2020
$6.46B(+10.5%)
$1.49B(-7.7%)
$6.44B(+3.2%)
Sep 2020
-
$1.62B(+3.1%)
$6.24B(+1.6%)
Jun 2020
-
$1.57B(-10.7%)
$6.14B(+2.1%)
Mar 2020
-
$1.76B(+35.9%)
$6.01B(+2.9%)
Dec 2019
$5.84B(-4.6%)
$1.29B(-14.9%)
$5.84B(-0.1%)
Sep 2019
-
$1.52B(+5.2%)
$5.85B(+1.9%)
Jun 2019
-
$1.44B(-9.2%)
$5.74B(-3.6%)
Mar 2019
-
$1.59B(+22.4%)
$5.96B(-3.0%)
Dec 2018
$6.12B(+5.4%)
$1.30B(-7.8%)
$6.14B(-0.1%)
Sep 2018
-
$1.41B(-15.0%)
$6.15B(-2.1%)
Jun 2018
-
$1.66B(-6.6%)
$6.28B(+3.1%)
Mar 2018
-
$1.77B(+35.8%)
$6.09B(+5.5%)
Dec 2017
$5.80B(+3.0%)
$1.31B(-15.4%)
$5.78B(+0.8%)
Sep 2017
-
$1.54B(+4.9%)
$5.73B(+1.3%)
Jun 2017
-
$1.47B(+1.1%)
$5.66B(-0.7%)
Mar 2017
-
$1.45B(+15.3%)
$5.70B(+1.0%)
Dec 2016
$5.64B(+8.7%)
$1.26B(-14.2%)
$5.64B(+0.9%)
Sep 2016
-
$1.47B(-2.9%)
$5.59B(+4.1%)
Jun 2016
-
$1.51B(+8.3%)
$5.37B(+5.5%)
Mar 2016
-
$1.40B(+15.4%)
$5.09B(-1.9%)
Dec 2015
$5.19B(+9.8%)
$1.21B(-3.0%)
$5.19B(+2.3%)
Sep 2015
-
$1.25B(+1.1%)
$5.08B(+1.9%)
Jun 2015
-
$1.24B(-17.4%)
$4.98B(-1.0%)
Mar 2015
-
$1.50B(+36.5%)
$5.03B(+6.6%)
Dec 2014
$4.72B(+5.3%)
$1.10B(-5.2%)
$4.72B(-0.2%)
Sep 2014
-
$1.16B(-10.1%)
$4.73B(+0.3%)
Jun 2014
-
$1.29B(+8.4%)
$4.72B(+2.3%)
Mar 2014
-
$1.19B(+7.3%)
$4.61B(+2.8%)
Dec 2013
$4.48B(+21.2%)
$1.10B(-3.1%)
$4.48B(+2.4%)
Sep 2013
-
$1.14B(-3.4%)
$4.38B(+4.5%)
Jun 2013
-
$1.18B(+11.4%)
$4.19B(+6.5%)
Mar 2013
-
$1.06B(+5.8%)
$3.93B(+6.4%)
Dec 2012
$3.70B(+15.9%)
$1.00B(+5.2%)
$3.70B(+4.3%)
Sep 2012
-
$951.38M(+3.1%)
$3.55B(+4.6%)
Jun 2012
-
$923.11M(+12.2%)
$3.39B(+3.8%)
Mar 2012
-
$822.39M(-3.1%)
$3.27B(+2.4%)
Dec 2011
$3.19B(+24.6%)
$849.02M(+6.6%)
$3.19B(+4.3%)
Sep 2011
-
$796.82M(-0.1%)
$3.06B(+6.1%)
Jun 2011
-
$797.80M(+6.8%)
$2.89B(+7.1%)
Mar 2011
-
$747.27M(+4.0%)
$2.69B(+5.0%)
Dec 2010
$2.56B(+27.2%)
$718.54M(+15.6%)
$2.56B(+11.2%)
Sep 2010
-
$621.46M(+2.5%)
$2.31B(+4.2%)
Jun 2010
-
$606.13M(-1.9%)
$2.21B(+2.7%)
Mar 2010
-
$618.08M(+34.1%)
$2.16B(+7.2%)
Dec 2009
$2.02B(+5.8%)
$460.96M(-12.9%)
$2.01B(+2.3%)
Sep 2009
-
$529.21M(-3.3%)
$1.96B(-0.3%)
Jun 2009
-
$547.32M(+15.7%)
$1.97B(+1.5%)
Mar 2009
-
$472.98M(+13.9%)
$1.94B(+1.8%)
Dec 2008
$1.90B(+21.3%)
$415.32M(-22.5%)
$1.91B(+13.2%)
Sep 2008
-
$536.09M(+3.4%)
$1.69B(+8.6%)
Jun 2008
-
$518.26M(+18.3%)
$1.55B(-8.4%)
Mar 2008
-
$438.21M(+127.1%)
$1.70B(+8.9%)
Dec 2007
$1.57B(+44.4%)
$192.97M(-52.1%)
$1.56B(-6.3%)
Sep 2007
-
$403.24M(-39.0%)
$1.66B(+6.4%)
Jun 2007
-
$660.90M(+120.1%)
$1.56B(+30.6%)
Mar 2007
-
$300.26M(+0.7%)
$1.20B(+9.6%)
Dec 2006
$1.09B(+11.1%)
$298.32M(-1.7%)
$1.09B(+11.0%)
Sep 2006
-
$303.39M(+3.1%)
$983.06M(+1.8%)
Jun 2006
-
$294.28M(+50.5%)
$965.83M(+1.1%)
Mar 2006
-
$195.49M(+2.9%)
$955.65M(-2.2%)
Dec 2005
$978.18M(+15.8%)
$189.90M(-33.6%)
$976.95M(-6.9%)
Sep 2005
-
$286.17M(+0.7%)
$1.05B(+8.7%)
Jun 2005
-
$284.09M(+31.0%)
$965.02M(+8.8%)
Mar 2005
-
$216.80M(-17.4%)
$887.21M(+4.4%)
Dec 2004
$844.42M
$262.34M(+30.0%)
$849.80M(+5.5%)
Sep 2004
-
$201.80M(-2.2%)
$805.71M(+3.9%)
DateAnnualQuarterlyTTM
Jun 2004
-
$206.27M(+15.0%)
$775.33M(+1.4%)
Mar 2004
-
$179.39M(-17.8%)
$764.74M(+3.0%)
Dec 2003
$741.69M(+42.5%)
$218.26M(+27.3%)
$742.37M(+9.0%)
Sep 2003
-
$171.41M(-12.4%)
$681.10M(+6.1%)
Jun 2003
-
$195.68M(+24.6%)
$642.19M(+16.5%)
Mar 2003
-
$157.01M(+0.0%)
$551.02M(+8.5%)
Dec 2002
$520.58M(+12.5%)
$156.99M(+18.5%)
$507.68M(+7.3%)
Sep 2002
-
$132.50M(+26.8%)
$473.21M(+1.4%)
Jun 2002
-
$104.51M(-8.1%)
$466.82M(+1.3%)
Mar 2002
-
$113.67M(-7.2%)
$461.02M(-2.7%)
Dec 2001
$462.85M(+20.9%)
$122.52M(-2.9%)
$473.81M(+11.7%)
Sep 2001
-
$126.12M(+27.8%)
$424.04M(-16.8%)
Jun 2001
-
$98.71M(-21.9%)
$509.81M(-3.4%)
Mar 2001
-
$126.46M(+73.8%)
$527.60M(+7.2%)
Dec 2000
$382.77M(+10.4%)
$72.75M(-65.7%)
$492.00M(-4.1%)
Sep 2000
-
$211.89M(+81.9%)
$512.95M(+31.3%)
Jun 2000
-
$116.50M(+28.2%)
$390.71M(+7.2%)
Mar 2000
-
$90.87M(-3.0%)
$364.40M(+4.9%)
Dec 1999
$346.71M(-3.9%)
$93.69M(+4.5%)
$347.42M(-0.5%)
Sep 1999
-
$89.65M(-0.6%)
$349.30M(-0.1%)
Jun 1999
-
$90.19M(+22.1%)
$349.59M(-4.7%)
Mar 1999
-
$73.88M(-22.7%)
$366.90M(-2.8%)
Dec 1998
$360.78M(+7.2%)
$95.58M(+6.3%)
$377.42M(-0.4%)
Sep 1998
-
$89.94M(-16.3%)
$378.85M(+0.8%)
Jun 1998
-
$107.51M(+27.4%)
$375.76M(+6.5%)
Mar 1998
-
$84.39M(-13.0%)
$352.69M(+6.5%)
Dec 1997
$336.55M(+8.2%)
$97.01M(+11.7%)
$331.07M(+5.9%)
Sep 1997
-
$86.84M(+2.8%)
$312.69M(+1.9%)
Jun 1997
-
$84.44M(+34.5%)
$306.98M(+1.8%)
Mar 1997
-
$62.77M(-20.2%)
$301.47M(-2.4%)
Dec 1996
$310.92M(+11.5%)
$78.64M(-3.1%)
$308.91M(+5.2%)
Sep 1996
-
$81.13M(+2.8%)
$293.59M(+0.6%)
Jun 1996
-
$78.93M(+12.4%)
$291.94M(-1.0%)
Mar 1996
-
$70.22M(+10.9%)
$294.77M(+6.4%)
Dec 1995
$278.96M(+23.7%)
$63.32M(-20.3%)
$276.96M(-6.3%)
Sep 1995
-
$79.48M(-2.8%)
$295.53M(+6.2%)
Jun 1995
-
$81.76M(+56.0%)
$278.26M(+16.1%)
Mar 1995
-
$52.41M(-36.0%)
$239.60M(+5.5%)
Dec 1994
$225.60M(+2.1%)
$81.90M(+31.7%)
$227.07M(+9.0%)
Sep 1994
-
$62.20M(+44.3%)
$208.38M(+0.8%)
Jun 1994
-
$43.10M(+8.1%)
$206.67M(-2.0%)
Mar 1994
-
$39.87M(-36.9%)
$210.89M(-2.8%)
Dec 1993
$220.90M(+4.5%)
$63.21M(+4.5%)
$217.00M(-1.3%)
Sep 1993
-
$60.49M(+27.8%)
$219.83M(+10.0%)
Jun 1993
-
$47.32M(+2.9%)
$199.79M(-3.1%)
Mar 1993
-
$45.98M(-30.4%)
$206.28M(-2.6%)
Dec 1992
$211.31M(+44.9%)
$66.04M(+63.3%)
$211.84M(+19.3%)
Sep 1992
-
$40.45M(-24.8%)
$177.55M(-0.0%)
Jun 1992
-
$53.81M(+4.4%)
$177.56M(+12.8%)
Mar 1992
-
$51.54M(+62.3%)
$157.35M(+7.7%)
Dec 1991
$145.82M(+18.4%)
$31.75M(-21.5%)
$146.09M(+2.4%)
Sep 1991
-
$40.46M(+20.4%)
$142.73M(+6.5%)
Jun 1991
-
$33.60M(-16.6%)
$134.02M(+1.6%)
Mar 1991
-
$40.28M(+41.9%)
$131.93M(+7.6%)
Dec 1990
$123.13M(+20.5%)
$28.39M(-10.6%)
$122.64M(+8.7%)
Sep 1990
-
$31.75M(+0.8%)
$112.81M(+4.8%)
Jun 1990
-
$31.51M(+1.7%)
$107.65M(+11.8%)
Mar 1990
-
$30.99M(+67.0%)
$96.27M(-5.9%)
Dec 1989
$102.21M(+7.6%)
$18.56M(-30.2%)
$102.30M(+0.9%)
Sep 1989
-
$26.59M(+32.1%)
$101.36M(+7.1%)
Jun 1989
-
$20.13M(-45.6%)
$94.65M(-11.9%)
Mar 1989
-
$37.02M(+110.0%)
$107.46M(+14.7%)
Dec 1988
$94.97M(+35.1%)
$17.63M(-11.3%)
$93.68M(-5.1%)
Sep 1988
-
$19.87M(-39.7%)
$98.71M(+2.9%)
Jun 1988
-
$32.94M(+41.7%)
$95.90M(+24.1%)
Mar 1988
-
$23.24M(+2.6%)
$77.27M(+7.7%)
Dec 1987
$70.31M(+8.8%)
$22.66M(+32.8%)
$71.77M(+7.1%)
Sep 1987
-
$17.06M(+19.2%)
$67.00M(+0.5%)
Jun 1987
-
$14.31M(-19.3%)
$66.70M(-2.5%)
Mar 1987
-
$17.74M(-0.9%)
$68.42M(+5.6%)
Dec 1986
$64.62M(+11.8%)
$17.89M(+6.8%)
$64.82M(+8.7%)
Sep 1986
-
$16.76M(+4.5%)
$59.62M(+3.6%)
Jun 1986
-
$16.03M(+13.4%)
$57.52M(+3.3%)
Mar 1986
-
$14.13M(+11.4%)
$55.70M(-2.3%)
Dec 1985
$57.81M(-12.9%)
$12.69M(-13.5%)
$57.03M(-7.0%)
Sep 1985
-
$14.67M(+3.2%)
$61.31M(-3.8%)
Jun 1985
-
$14.21M(-8.1%)
$63.76M(-2.9%)
Mar 1985
-
$15.46M(-8.9%)
$65.68M(-1.2%)
Dec 1984
$66.41M
$16.97M(-0.8%)
$66.51M(+34.3%)
Sep 1984
-
$17.11M(+6.1%)
$49.54M(+52.8%)
Jun 1984
-
$16.14M(-1.0%)
$32.43M(+99.0%)
Mar 1984
-
$16.29M
$16.29M

FAQ

  • What is Novo Nordisk A/S annual net profit?
  • What is the all time high annual net income for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual net income year-on-year change?
  • What is Novo Nordisk A/S quarterly net profit?
  • What is the all time high quarterly net income for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly net income year-on-year change?
  • What is Novo Nordisk A/S TTM net profit?
  • What is the all time high TTM net income for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM net income year-on-year change?

What is Novo Nordisk A/S annual net profit?

The current annual net income of NVO is $14.65B

What is the all time high annual net income for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual net profit is $14.65B

What is Novo Nordisk A/S annual net income year-on-year change?

Over the past year, NVO annual net profit has changed by +$2.50B (+20.60%)

What is Novo Nordisk A/S quarterly net profit?

The current quarterly net income of NVO is $4.03B

What is the all time high quarterly net income for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly net profit is $4.03B

What is Novo Nordisk A/S quarterly net income year-on-year change?

Over the past year, NVO quarterly net profit has changed by $0.00 (0.00%)

What is Novo Nordisk A/S TTM net profit?

The current TTM net income of NVO is $14.65B

What is the all time high TTM net income for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM net profit is $14.65B

What is Novo Nordisk A/S TTM net income year-on-year change?

Over the past year, NVO TTM net profit has changed by $0.00 (0.00%)
On this page